Catalyst Wire Dossier Catalyst Wire Dossier

Allogeneic Expanded Human MSC Therapy

allogeneic mesenchymal stem cells · BioCardia, Inc.
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Allogeneic Expanded Human MSC Therapy, covering 2026-01-07 to 2026-01-07. Get the full timeline:

Most recent: Clinical Trial Update: AllogeneiC Expanded Human MSC Therapy in Patients Recovering From COVID-19 Acute Respiratory Distress Trial [Phase 1]

See pricing